Ensign Peak Advisors’s Opko Health OPK Stock Holding History

Ensign Peak Advisors’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-23,210	Closed	-$80K	–	2193
2022 Q1	$80K	Buy	+23,210	New	+$82K	﹤0.01%	2074

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ensign Peak Advisors's OPK Position: Q2 2022 in Review

Ensign Peak Advisors sold out of Opko Health (OPK) in Q2 2022, closing a stake of 23,210 shares — an estimated $80K sold.

Ensign Peak Advisors first reported a position in OPK in Q1 2022 and held it in 1 quarter. The position peaked at $80K in Q1 2022. 231 funds tracked by Wall St. Rank hold OPK as of Q2 2022.

Ensign Peak Advisors reported no remaining Opko Health position as of Q2 2022 after selling out during the quarter.
Ensign Peak Advisors sold 23,210 Opko Health shares in Q2 2022, an estimated $80K.
Ensign Peak Advisors first reported a position in Opko Health in Q1 2022 and held it in 1 quarter.
Ensign Peak Advisors's Opko Health position peaked at $80K in Q1 2022.
231 funds tracked by Wall St. Rank held Opko Health as of Q2 2022.

Based on Ensign Peak Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.